Cargando…

Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms

Presently, nanocarriers (NCs) have gained huge attention for their structural ability, good biocompatibility, and biodegradability. The development of effective NCs with stimuli-responsive properties has acquired a huge interest among scientists. When developing drug delivery NCs, the fundamental go...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaushik, Neha, Borkar, Shweta B., Nandanwar, Sondavid K., Panda, Pritam Kumar, Choi, Eun Ha, Kaushik, Nagendra Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944113/
https://www.ncbi.nlm.nih.gov/pubmed/35331246
http://dx.doi.org/10.1186/s12951-022-01364-2
_version_ 1784673652928675840
author Kaushik, Neha
Borkar, Shweta B.
Nandanwar, Sondavid K.
Panda, Pritam Kumar
Choi, Eun Ha
Kaushik, Nagendra Kumar
author_facet Kaushik, Neha
Borkar, Shweta B.
Nandanwar, Sondavid K.
Panda, Pritam Kumar
Choi, Eun Ha
Kaushik, Nagendra Kumar
author_sort Kaushik, Neha
collection PubMed
description Presently, nanocarriers (NCs) have gained huge attention for their structural ability, good biocompatibility, and biodegradability. The development of effective NCs with stimuli-responsive properties has acquired a huge interest among scientists. When developing drug delivery NCs, the fundamental goal is to tackle the delivery-related problems associated with standard chemotherapy and to carry medicines to the intended sites of action while avoiding undesirable side effects. These nanocarriers were able of delivering drugs to tumors through regulating their pH, temperature, enzyme responsiveness. With the use of nanocarriers, chemotherapeutic drugs could be supplied to tumors more accurately that can equally encapsulate and deliver them. Material carriers for chemotherapeutic medicines are discussed in this review keeping in viewpoint of the structural properties and targeting methods that make these carriers more therapeutically effective, in addition to metabolic pathways triggered by drug-loaded NCs. Largely, the development of NCs countering to endogenous and exogenous stimuli in tumor regions and understanding of mechanisms would encourage the progress for tumor therapy and precision diagnosis in future. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-8944113
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89441132022-03-25 Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms Kaushik, Neha Borkar, Shweta B. Nandanwar, Sondavid K. Panda, Pritam Kumar Choi, Eun Ha Kaushik, Nagendra Kumar J Nanobiotechnology Review Presently, nanocarriers (NCs) have gained huge attention for their structural ability, good biocompatibility, and biodegradability. The development of effective NCs with stimuli-responsive properties has acquired a huge interest among scientists. When developing drug delivery NCs, the fundamental goal is to tackle the delivery-related problems associated with standard chemotherapy and to carry medicines to the intended sites of action while avoiding undesirable side effects. These nanocarriers were able of delivering drugs to tumors through regulating their pH, temperature, enzyme responsiveness. With the use of nanocarriers, chemotherapeutic drugs could be supplied to tumors more accurately that can equally encapsulate and deliver them. Material carriers for chemotherapeutic medicines are discussed in this review keeping in viewpoint of the structural properties and targeting methods that make these carriers more therapeutically effective, in addition to metabolic pathways triggered by drug-loaded NCs. Largely, the development of NCs countering to endogenous and exogenous stimuli in tumor regions and understanding of mechanisms would encourage the progress for tumor therapy and precision diagnosis in future. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2022-03-24 /pmc/articles/PMC8944113/ /pubmed/35331246 http://dx.doi.org/10.1186/s12951-022-01364-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Kaushik, Neha
Borkar, Shweta B.
Nandanwar, Sondavid K.
Panda, Pritam Kumar
Choi, Eun Ha
Kaushik, Nagendra Kumar
Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms
title Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms
title_full Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms
title_fullStr Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms
title_full_unstemmed Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms
title_short Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms
title_sort nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944113/
https://www.ncbi.nlm.nih.gov/pubmed/35331246
http://dx.doi.org/10.1186/s12951-022-01364-2
work_keys_str_mv AT kaushikneha nanocarriercancertherapeuticswithfunctionalstimuliresponsivemechanisms
AT borkarshwetab nanocarriercancertherapeuticswithfunctionalstimuliresponsivemechanisms
AT nandanwarsondavidk nanocarriercancertherapeuticswithfunctionalstimuliresponsivemechanisms
AT pandapritamkumar nanocarriercancertherapeuticswithfunctionalstimuliresponsivemechanisms
AT choieunha nanocarriercancertherapeuticswithfunctionalstimuliresponsivemechanisms
AT kaushiknagendrakumar nanocarriercancertherapeuticswithfunctionalstimuliresponsivemechanisms